Account
Pidilite onboards Art-E Mediatech as digital technology partner
Mumbai: The full stack agency Art-E Mediatech has won the digital technology partner mandate for Pidilite Industries Ltd, a market leader in adhesive, industrial and construction chemicals, and art material. The partnership focuses on building a strategic and streamlined digital brand experience for Pidilite.
Art-E Mediatech will design, develop and manage the digital platforms for the multiple brands & products like Fevicol Design Ideas, Dr Fixit, One Pidilite, ICA, Dr Cipy, industrial products and the pigment business, said the statement.
Speaking of this association, Pidilite Industries Ltd chief marketing officer Vinay Subramanyam commented, “Art-E Mediatech is a valuable and strategic partner and shares our quest of delivering industry leading brand experiences across platforms.”
He further added, “Art-E Mediatech’s capabilities to understand various user journeys of our customers and translate them into an effective outcome based digital experience is what we are looking forward to.”
Art-E Mediatech chief digital officer Preetesh Chouhan said, “We are delighted & thrilled to partner with Pidilite, which is a consumer centric company committed to quality and innovation for decades. Over the years we have built a strong reputation in the areas of digital experience solutions & delivery and we’ll be utilising our full stack capabilities in building cutting edge digital brand experiences for Pidilite customers & partners.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
